A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial

Jenny L. Donovan*, Grace J. Young, Eleanor I. Walsh, Chris Metcalfe, J. Athene Lane, Richard M. Martin, Marta K. Tazewell, Michael Davis, Tim J. Peters, Emma L. Turner, Nicola Mills, Hanan Khazragui, Tarnjit K. Khera, David E. Neal, Freddie C. Hamdy, Prasad Bollina, James Catto, Andrew Doble, Alan Doherty, David GillattVincent Gnanapragasam, Peter Holding, Owen Hughes, Roger Kockelbergh, Howard Kynaston, Malcolm Mason, Jon Oxley, Alan Paul, Edgar Paez, Derek J. Rosario, Edward Rowe, John Staffurth, the ProtecT Study Group

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

6 Citations (Scopus)
303 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial'. Together they form a unique fingerprint.

Medicine & Life Sciences